BIOMARKERS OF BONE MINERAL ALTERATION IN PATIENTS WITH END-STAGE CHRONIC KIDNEY DISEASE ON HAEMODIALYSIS IN THE PERIOD FROM JANUARY TO DECEMBER 2018
Article Sidebar
Main Article Content
Abstract
Alterations in mineral and bone metabolism associated with chronic kidney disease represent an important set of abnormalities and have been associated with an increase in morbidity, mortality and risk of quality of life in chronic renal patients.2
The reason for which this research work is carried out, is that it determines the association between hyperphosphatemia, hyperparathyroidism, calcium alteration with increased mortality in patients in stage 5D.
The renal unit of DIALCIVAR, consists of patients in
which a sample of 100 patients has been randomly selected. It is a retrospective, cross-sectional study, using the periodic examinations that are performed, subsequently obtaining the statistical data, which indicate us that our study population presents bone mineral alteration, with a predominance of Paratohormone in ----% and % phosphorus, at an average
age of 54 years, presenting a high risk of cardiovascular morbidity.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.